Rotasiil-Liquid Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Concise Prescribing Info

Contents

Live attenuated rotavirus vaccine

Indications/Uses

Active immunization of healthy infants from 6 wk for the prevention of gastroenteritis due to rotavirus infection.

Click to view Rotasiil-Liquid detailed prescribing information

Dosage/Direction for Use

Administer orally as 3-dose regimen, 4 wk apart, beginning at 6 wk. The 3-dose regimen should be completed by 1 yr.

Click to view Rotasiil-Liquid detailed prescribing information

Overdosage

View Rotasiil-Liquid overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Severe combined immunodeficiency disease. History of intussusception. Infants w/ history of uncorrected congenital malformation of the GI tract predisposing to intussusception.

Click to view Rotasiil-Liquid detailed prescribing information

Special Precautions

Not to be administered parenterally. Delay administration in acute infection or febrile illness. Carefully evaluate cases w/ symptoms suggestive of intussusception. May not protect all recipients against rotavirus infection. Not for protection against gastroenteritis caused by other pathogens. Interchangeability w/ other rotavirus vaccines. Not indicated for adults including women of childbearing age. Not to be administered during pregnancy. Infants who are immunocompromised, w/ HIV or chronic gastroenteritis; in close contact w/ immunodeficient persons. Not recommended in childn >24 mth.

Click to view Rotasiil-Liquid detailed prescribing information

Use In Pregnancy & Lactation

Click to view Rotasiil-Liquid detailed prescribing information

Adverse Reactions

Fever, irritability, decreased appetite & activity level, vomiting, diarrhea.

Click to view Rotasiil-Liquid detailed prescribing information

Drug Interactions

Immune response may be reduced w/ immunosuppressive therapies including irradiation, antimetabolites, alkylating agents, cytotoxic drugs & corticosteroids (used in minimal dose).

Click to view Rotasiil-Liquid detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Rotasiil-Liquid detailed prescribing information

Storage

View Rotasiil-Liquid storage conditions for details to ensure optimal shelf-life.

Description

View Rotasiil-Liquid description for details of the chemical structure and excipients (inactive components).

Action

View Rotasiil-Liquid mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BH02 - rota virus, pentavalent, live, reassorted ; Belongs to the class of rota virus diarrhea vaccines.

Regulatory Classification

Presentation/Packing

Form

Rotasiil-Liquid oral susp 2 mL

Packing/Price

1's;50 × 1's

Rotasiil-Liquid

rotavirus vaccine

Manufacturer:

Serum Institute of India

Distributor:

Faberco